CV SCIENCES, INC. Form 8-K Filing

This filing details amendments to a secured promissory note originally issued by CV Sciences, Inc. to an institutional investor. Key amendments include the ability to convert the outstanding balance into common stock at a fixed price of $0.03 per share, and an extension of the maturity date for a third note to July 6, 2027. The company has also issued a third note with a principal amount of $99,614.04. The filing incorporates by reference exhibits detailing the Senior Secured Convertible Note and the April Amendment, which outlines the conversion price and maturity date adjustments. The company has agreed to reserve shares for conversion and maintain public information requirements.